New York State Common Retirement Fund Has $4.49 Million Stock Holdings in Stericycle, Inc. (NASDAQ:SRCL)

New York State Common Retirement Fund cut its position in shares of Stericycle, Inc. (NASDAQ:SRCL) by 11.9% during the 4th quarter, Holdings Channel reports. The firm owned 90,685 shares of the business services provider’s stock after selling 12,198 shares during the quarter. New York State Common Retirement Fund’s holdings in Stericycle were worth $4,494,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently modified their holdings of SRCL. Ariel Investments LLC increased its stake in shares of Stericycle by 5.7% during the 3rd quarter. Ariel Investments LLC now owns 4,328,036 shares of the business services provider’s stock worth $193,506,000 after purchasing an additional 233,612 shares during the last quarter. Robeco Schweiz AG grew its stake in Stericycle by 17.6% in the 3rd quarter. Robeco Schweiz AG now owns 1,019,692 shares of the business services provider’s stock valued at $45,590,000 after buying an additional 152,780 shares during the last quarter. Impax Asset Management Group plc grew its stake in Stericycle by 4.9% in the 4th quarter. Impax Asset Management Group plc now owns 3,139,032 shares of the business services provider’s stock valued at $154,396,000 after buying an additional 147,452 shares during the last quarter. Envestnet Asset Management Inc. grew its stake in Stericycle by 62.3% in the 3rd quarter. Envestnet Asset Management Inc. now owns 329,971 shares of the business services provider’s stock valued at $14,753,000 after buying an additional 126,700 shares during the last quarter. Finally, Earnest Partners LLC grew its stake in Stericycle by 6.6% in the 3rd quarter. Earnest Partners LLC now owns 1,941,254 shares of the business services provider’s stock valued at $86,793,000 after buying an additional 120,852 shares during the last quarter. 98.82% of the stock is currently owned by institutional investors and hedge funds.

Stericycle Trading Up 3.1 %

NASDAQ SRCL opened at $46.18 on Friday. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.11 and a quick ratio of 1.11. Stericycle, Inc. has a 12-month low of $37.78 and a 12-month high of $57.06. The firm has a 50-day moving average price of $50.91 and a two-hundred day moving average price of $48.25.

Stericycle (NASDAQ:SRCL) last posted its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.03. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The firm had revenue of $664.90 million during the quarter, compared to the consensus estimate of $676.42 million. During the same quarter in the previous year, the firm posted $0.49 EPS. The business’s revenue for the quarter was down 2.8% compared to the same quarter last year. On average, equities analysts predict that Stericycle, Inc. will post 2.32 earnings per share for the current year.

Analyst Ratings Changes

A number of research analysts recently commented on the stock. StockNews.com lowered shares of Stericycle from a “buy” rating to a “hold” rating in a research note on Tuesday, April 2nd. Royal Bank of Canada reiterated an “outperform” rating and issued a $69.00 price target on shares of Stericycle in a research note on Thursday, March 7th. Wells Fargo & Company upped their price target on shares of Stericycle from $40.00 to $48.00 and gave the company an “underweight” rating in a research note on Friday, March 1st. Truist Financial decreased their price target on shares of Stericycle from $57.00 to $50.00 and set a “hold” rating on the stock in a research note on Monday, April 29th. Finally, Stifel Nicolaus boosted their price objective on shares of Stericycle from $70.00 to $75.00 and gave the company a “buy” rating in a report on Thursday, February 29th. One analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $59.40.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.